Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    No substantive changes to the study details are visible between the two screenshots; the content appears unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T14:19:59.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Updated core content with an operating-status notice and a new version (v3.2.0); removed a previous term and older version marker (v3.1.0).
    Difference
    1%
    Check dated 2025-10-06T04:24:57.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Expanded immunology and biomarker terminology and updated cancer nomenclature and page version (from v3.0.2 to v3.1.0).
    Difference
    0.5%
    Check dated 2025-09-29T00:00:22.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page has advanced to Revision: v3.0.2 with September 2025 updates, replacing the older v3.0.1 entries and removing earlier timestamps; a minor UI element ('Back to Top') was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:45:53.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version and the addition of a Diagnostic CAT Scan service type, while previous update dates and version information have been removed.
    Difference
    0.5%
    Check dated 2025-09-07T13:07:34.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has added significant information regarding facility names, locations, and specific medical studies related to cancer treatments, while removing outdated location details and certain cancer types. Notably, the addition of a new trial and its results enhances the page's relevance in the context of advanced cancer therapies.
    Difference
    6%
    Check dated 2025-08-31T04:28:42.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.